Log in

Relevant bibliographies by topics / C-reactive protein Autoimmune Omega-3 fatty acid High-senstive CRP

Contents

Journal articles

Academic literature on the topic 'C-reactive protein Autoimmune Omega-3 fatty acid High-senstive CRP'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'C-reactive protein Autoimmune Omega-3 fatty acid High-senstive CRP.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "C-reactive protein Autoimmune Omega-3 fatty acid High-senstive CRP"

1

I, Kadek Sumantara Artha, and Agung Ayu Ratih Dharmaiswari Anak. "The Correlation of Omega-3 Supplementation with CRP As Marker Inflammation in Autoimmune Diseases." International Journal of Medical Science and Clinical Research Studies 5, no. 05 (2025): 686–95. https://doi.org/10.5281/zenodo.15347928.

Full text

Abstract:

Introduction: Omega-3 fatty acids are a type of polyunsaturated fatty acids (PUFAs) are regarded as anti-inflammatory lipids. The occurrence of diseases with an inflammatory aspect, including acute myocardial infarction, diabetes mellitus, autoimmune diseases such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis vulgaris, type 1 diabetes mellitus (T1DM), inflammatory bowel diseases (IBD) and systemic lupus erythematosus (SLE). Omega 3 can reduce inflammatory factor such as CRP (C- reactive protein) or hsCRP (High sensitive c-reactive protein). Objective: This systematic review

APA, Harvard, Vancouver, ISO, and other styles

2

Dong, Yanbin, Haidong Zhu, Li Chen, et al. "Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial." Nutrients 14, no. 24 (2022): 5307. http://dx.doi.org/10.3390/nu14245307.

Full text

Abstract:

Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements. We recently reported that vitamin D supplementation with or without omega 3 fatty acids reduced autoimmune disease by 22% in the VITAL study. Objective: To investigate the effects of vitamin D3 and/or n-3 FAs on changes in systemic inflammatory biomarkers including pro- and anti-inflammatory cytokines over a 4-year period in the VITAL sub-cohort with in-person evaluations at the Center for Clinical Investigations

APA, Harvard, Vancouver, ISO, and other styles

3

Perez-Sanchez, C., L. Muñoz-Barrera, T. Cerdó, et al. "POS1041 LIPID METABOLISM IS DEEPLY ALTERED IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS AND REVERSED BY ANTI-TNF, ANTI-IL6R, AND JAK-INHIBITORS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 838.1–838. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3821.

Full text

Abstract:

BackgroundSince lipid metabolism impact immune cell plasticity regulating cell activation, differentiation and function, the extensive analysis of the lipidomic profile using novel high-throughput metabolomic techniques in chronic inflammatory diseases such as Rheumatoid Arthritis (RA) might contribute to better characterise the pathogenesis of the disease.ObjectivesTo analyse the whole lipidomic profile in the serum of RA patients, its association with the disease activity and its modulation by biological and targeted synthetic therapies.MethodsTwo hundred and fifty consecutive RA patients we

APA, Harvard, Vancouver, ISO, and other styles

4

Megawati, Ginna, Noormarina Indraswari, Alexandra Aurelia Johansyah, et al. "Comparison of hs-CRP in Adult Obesity and Central Obesity in Indonesia Based on Omega-3 Fatty Acids Intake: Indonesian Family Life Survey 5 (IFLS 5) Study." International Journal of Environmental Research and Public Health 20, no. 18 (2023): 6734. http://dx.doi.org/10.3390/ijerph20186734.

Full text

Abstract:

Obesity and central obesity are associated with dire conditions, such as metabolic syndrome, in which low-grade inflammation plays a part. C-reactive protein (CRP) is an inflammatory marker found to be elevated in those conditions. Omega-3 fatty acids work against inflammation and lower CRP levels in obese individuals. This study compared high-sensitivity CRP (hs-CRP) in adult obesity and central obesity in Indonesia based on omega-3 fatty acid intake using Indonesian Family Life Survey (IFLS) 5 data. Secondary data from household questionnaires were obtained from the IFLS 5 online database. D

APA, Harvard, Vancouver, ISO, and other styles

5

Lindahl, *Jesper, Klara Suneson, Gustav Söderberg, et al. "OMEGA-3 FATTY ACIDS FOR INFLAMED DEPRESSION – A MATCH/MISMATCH STUDY." International Journal of Neuropsychopharmacology 28, Supplement_1 (2025): i195. https://doi.org/10.1093/ijnp/pyae059.338.

Full text

Abstract:

Abstract Background Despite decades of research on the pathophysiology of depression, the development of new therapeutic interventions has been slow, and no biomarkers of treatment response have been clinically implemented. Several lines of evidence suggets that the clinical and biological heterogeneity among patients with major depressive disorder (MDD) has hampered progress in this field. MDD with low-grade inflammation - "inflamed depression" - is a subtype of depression that may be associated with the superior antidepressant treatment response to anti-inflammatory compounds. Omega-3 fatty

APA, Harvard, Vancouver, ISO, and other styles

6

Jafari Salim, Shirin, Shahab Alizadeh, Mahmoud Djalali, Ebrahim Nematipour, and Mohammad Hassan Javanbakht. "Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial." American Journal of Men's Health 11, no. 6 (2017): 1758–64. http://dx.doi.org/10.1177/1557988317720581.

Full text

Abstract:

Adipokines are mediators of body composition and are involved in obesity-related complications such as cardiovascular disease. Omega-3 supplementation has not been studied in the setting of body composition and follistatin-like 1 (FSTL1) levels in patients with coronary artery disease (CAD). This study aimed to investigate the effect of omega-3 polyunsaturated fatty acid (ω-3 PUFA) supplementation on body composition indices and serum levels of FSTL1 in CAD patients. A total of 42 male (aged 45–65 years) subjects with angiographically confirmed CAD were included in this randomized, double-blin

APA, Harvard, Vancouver, ISO, and other styles

7

Kopp, Lena, Anna Schweinlin, Lina Tingö, et al. "Potential Modulation of Inflammation and Physical Function by Combined Probiotics, Omega-3 Supplementation and Vitamin D Supplementation in Overweight/Obese Patients with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial." International Journal of Molecular Sciences 24, no. 10 (2023): 8567. http://dx.doi.org/10.3390/ijms24108567.

Full text

Abstract:

Obesity is characterized by low-grade inflammation and increased gut permeability. Here, we aim to evaluate the effect of a nutritional supplement on these parameters in subjects with overweight and obesity. A double-blinded, randomized clinical trial was conducted in 76 adults with overweight or obesity (BMI 28 to 40) and low-grade inflammation (high-sensitivity C-reactive protein (hs-CRP) between 2 and 10 mg/L). The intervention consisted of a daily intake of a multi-strain probiotic of Lactobacillus and Bifidobacterium, 640 mg of omega-3 fatty acids (n-3 FAs), and 200 IU of vitamin D (n = 3

APA, Harvard, Vancouver, ISO, and other styles

8

Simopoulos, Artemis P. "Genetic Variation, Diet, Inflammation, and the Risk for COVID-19." Lifestyle Genomics 14, no. 2 (2021): 37–42. http://dx.doi.org/10.1159/000513886.

Full text

Abstract:

COVID-19, which is caused by SARS-CoV-2, is characterized by various symptoms, ranging from mild fatigue to life-threatening pneumonia, “cytokine storm,” and multiorgan failure. The manifestation of COVID-19 may lead to a cytokine storm, i.e., it facilitates viral replication that triggers a strong release of cytokines, which then modulates the immune system and results in hyperinflammation. Today’s diet is high in omega-6 fatty acids and deficient in omega-3 fatty acids; this, along with a high fructose intake, leads to obesity, which is a chronic state of low-grade inflammation. Omega-6 fatt

APA, Harvard, Vancouver, ISO, and other styles

9

Lin, Ya-Ling, Chia-Liang Wang, Kai-Li Liu, Cheng-Nan Yeh, and Tsay-I. Chiang. "Omega-3 Fatty Acids Improve Chronic Kidney Disease—Associated Pruritus and Inflammation." Medicina 58, no. 6 (2022): 796. http://dx.doi.org/10.3390/medicina58060796.

Full text

Abstract:

Background and Objectives: Chronic kidney disease-associated pruritus (CKD-aP) is a common symptom in hemodialysis patients. A frequent and intense itching sensation largely torments patients, impacts quality of life outcomes, and it has an independent association with mortality. The objective of this study is to investigate the effects of oral supplementation with omega-3 polyunsaturated fatty acid (omega-3 PUFA) on circulating interleukin-6 (IL-6), cardiometabolic parameters, skin moisturization, and the consequent symptoms of pruritus in hemodialysis patients. Materials and Methods: Volunte

APA, Harvard, Vancouver, ISO, and other styles

10

Sony Sanjaya, Febria Suryani, Pham Uyen, Maria Rodriguez, and Muhammad Yoshandi. "Preventing Cognitive Decline in Late-Life Depression: A Longitudinal Study on the Efficacy of Omega-3 Fatty Acid Supplementation in Older Adults in Palembang, Indonesia." Scientia Psychiatrica 6, no. 2 (2025): 736–47. https://doi.org/10.37275/scipsy.v6i2.190.

Full text

Abstract:

Introduction: Late-life depression (LLD) is a prevalent condition in older adults and a significant risk factor for cognitive decline and dementia. In Indonesia, with its aging population and specific dietary patterns, understanding interventions for LLD-associated cognitive impairment is crucial. Omega-3 polyunsaturated fatty acids (PUFAs) offer potential neuroprotective benefits. This study aimed to assess the efficacy of long-term omega-3 PUFA supplementation in mitigating cognitive decline among older adults with LLD in Palembang, Indonesia. Methods: This 24-month, randomized, double-blind

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!